Summary
Overview
Work History
Education
Skills
Websites
Awarded Positions
Accomplishments
Timeline
Generic

Kevin P. Francis

Alameda,CA

Summary

Seasoned executive with a proven track record at PerkinElmer, adept in R&D and business leadership. Spearheaded innovative imaging technologies, significantly enhancing product development and sales strategies. Excelled in stakeholder relations, driving revenue growth and fostering industry advancements.

Overview

26
26
years of professional experience

Work History

Director

University of California
Los Angeles
06.2024 - Current
  • Direct the day-to-day running of the preclinical imaging core
  • Co-supervise a team of graduate, MD, and PhD scientists to conduct preclinical imaging studies
  • Promote imaging services across UCLA
  • Help to design and cost-out studies
  • Write manuscripts and grant proposals.

Divisional Vice President

PerkinElmer, Revvity
Alameda, CA
01.2013 - 12.2023
  • Strategy and Innovation
  • Applied forward-thinking enhancements to shape effective product development.
  • Identify and assess company acquisition and strategic investment opportunities (e.g., SonoVol in 2022).
  • Developed and solidified sales opportunities through direct engagement with commercial and academic clients.
  • Guiding R&D efforts within PerkinElmer and externally through academic collaborators, devising and developing novel imaging methodologies, and helping drive $100 million in annual equipment and consumables sales.

Divisional Vice President

Caliper Life Science
Alameda, CA
01.2008 - 12.2012
  • Directing preclinical and molecular biology R&D
  • Developed innovative methods alongside senior sales and marketing executives to enhance company earnings, increasing annual sales revenue from $20 to 40 million between 2008 - 2012.
  • Delivered published and innovative preclinical imaging data to academic and commercial clients worldwide.

Sr Director

Xenogen Corporation
Alameda, CA
06.2003 - 12.2007
  • Directing a team of PhD and DVM scientists in providing clients with solutions to technical problems associated with molecular biology and animal modeling across multiple disease areas (e.g., oncology and ID).
  • Supplied clients with critical resources and expertise for designing and executing experiments utilizing in-house systems.
  • Providing in-depth assessments of competing technologies and IP.
  • Showcased Xenogen’s technology to international clients supporting sales efforts.

Director

Xenogen Corporation
Alameda, CA
01.1999 - 06.2003
  • Directing a group of research scientists and facilitating the day-to-day running of a molecular biology/microbiology section, including budgeting and managing expenditures.
  • Identifying and developing new molecular techniques for improving the company’s core technology offering.
  • Developed and supplied animal models tailored for human infectious disease research.

Education

Ph.D - Molecular Microbiology

University of Edinburgh
UK
01.1993

MSc - Microbiology

Birkbeck College, University of London
UK
01.1989

Skills

  • Cross-Functional Collaboration
  • Multitasking and organization
  • Problem-solving
  • Industry knowledge
  • R&D Leadership
  • Creativity and innovation
  • Customer-Centric Sales
  • Marketing Insight

Awarded Positions

  • 09/01/21, Present, University of California, Los Angeles, CA, Adjunct Professor, Co-supervise a team of graduate, MD, and PhD scientists to conduct preclinical imaging studies in the Orthopaedic Hospital Research Center.
  • 10/01/15, 09/30/21, University of California, Los Angeles, CA, Visiting Professor, Help further collaborative efforts between scientists in the Orthopaedic Hospital Research Center and other laboratories in the SOM and the College.
  • 01/01/17, Present, Texas A&M University, College Station, TX, Visiting Professor, Collaborate and supervise molecular biology and imaging studies involving respiratory pathogens.
  • 01/01/13, 10/31/15, Imperial College, London, UK, Visiting Professor, Co-supervise a team of Molecular Microbiologists to develop novel ID models.
  • 02/01/08, Present, University Medical Center Groningen, The Netherlands, Honorary Research Professor, Assist in directing the research activities of the microbiology and oncology teams.

Accomplishments

  • President’s Circle Award for Business Accomplishment
  • Published more that 100 peer reviewed scientific papers and book chapters
  • Presented business information and scientific data to hundreds of Pharmaceutical, Biotechnology and Academic institutes across the world

Timeline

Director

University of California
06.2024 - Current

Divisional Vice President

PerkinElmer, Revvity
01.2013 - 12.2023

Divisional Vice President

Caliper Life Science
01.2008 - 12.2012

Sr Director

Xenogen Corporation
06.2003 - 12.2007

Director

Xenogen Corporation
01.1999 - 06.2003

Ph.D - Molecular Microbiology

University of Edinburgh

MSc - Microbiology

Birkbeck College, University of London
Kevin P. Francis